ACCP

(redirected from Anti-Cyclic Citrullinated Peptide)
AcronymDefinition
ACCPAmerican College of Chest Physicians
ACCPAmerican College of Clinical Pharmacy
ACCPAlliance for Cervical Cancer Prevention (est. 1999)
ACCPAssociation Canadienne des Chefs de Police (French: Canadian Association of Chiefs of Police)
ACCPArmy Correspondence Course Program
ACCPApproval Committee for Certificate Programs (American Academy of Professional Coders)
ACCPAtlantic Climate Change Program
ACCPAssociation of Caribbean Commissioners of Police
ACCPAmerican College of Contingency Planners (American Association of Medical Administrators)
ACCPAssociation of Corporate Contributions Professionals (Mt. Pleasant, SC)
ACCPAnti-Cyclic Citrullinated Peptide
ACCPAssembly of Caribbean Community Parliamentarians
ACCPAssociation Canadienne des Chefs de Pompiers (French: Canadian Association of Fire Chiefs; Ottawa, Ontario, Canada)
ACCPAssociation of Chinese Canadian Professionals (Canada)
ACCPAustralian Centre for Cleaner Production
ACCPAutomatic Credit Card Payment
ACCPAllied Combat Clothing Publication
ACCPAssociate Certified Coach Program
ACCPAssociation des Collectionneurs de Carnets de Timbres et de Publicitimbres (French stamp collecting club)
ACCPArmy Contingency Communications Package
ACCPAuto-Created Client Printer
ACCPAccelerated Case Closure Procedures
ACCPAccuracy Critical Control Points
ACCPAmerican Chemistry Council Panel
ACCPAptech Computer Certified Professional (Aptech Ltd.)
ACCPAssociation Clean Cuisines Professionnelles (French: Professional Kitchen Cleaning Association)
References in periodicals archive ?
It is also still unclear whether the IL1F7 gene is related to different RA subsets based on the status of anti-cyclic citrullinated peptide (CCP) antibody, rheumatoid factor (RF), or gender.
Anti-cyclic citrullinated peptide antibodies as a discriminating marker between rheumatoid arthritis and chronic hepatitis C-related polyarthropathy.
Anti-cyclic citrullinated peptide (CCP) detection is one of the latest markers that have been introduced for the diagnosis of RA.
The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register.
When a clinician uses the European SCORE (Systemic Coronary Risk Evaluation) formula to calculate an RA patient's 10-year risk for cardiovascular disease death, the number should be increased by 50% to get the patient's actual risk when at least two of the following three criteria are present: disease duration of more than 10 years, positivity for rheumatoid factor or anti-cyclic citrullinated peptide antibody, or extra-articular manifestations.
Multivariate analysis revealed that the strongest predictor of RA development was a positive titer of anti-cyclic citrullinated peptide (CCP) at presentation, with an odds ratio of 73.
A new test--the anti-cyclic citrullinated peptide antibody (anti-CCP)--is highly specific for RA (96%) and thus less likely than RF to give a false-positive result.
Such research led to the development of the anti-cyclic citrullinated peptide (anti-CCP) assay, which detects the presence of anti-citrullinated peptide autoantibodies found in the serum of many patients with RA.
Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement.
Patients with early arthritis should be evaluated for factors predictive of persistent and erosive disease, including number of swollen and tender joints, erythrocyte sedimentation rate or C-reactive protein, rheumatoid factor, anti-cyclic citrullinated peptide antibodies, and radiographic erosions.
Full browser ?